(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACOFIDE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ACOFIDE

ST13

US500000079312758

Class

5

Filing

79312758

Registration

6696217

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

08/08/2022

Trademark type

Combined

Nice classes

5

Filing date

04/13/2021

Registration date

04/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/12/2022

Last transaction

04/12/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

JP

Examiner

MACFARLANE, JAMES W

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ZERIA Pharmaceutical Co., Ltd.

Representatives

ZERIA Pharmaceutical Co., Ltd.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders

Publications

History of USPTO decisions and trademark events.

16 publications found

GPNX

NOTIFICATION PROCESSED BY IB

08/08/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/18/2022

FIMP

FINAL DISPOSITION PROCESSED

07/18/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

05/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2022

PUBO

PUBLISHED FOR OPPOSITION

01/25/2022

GPNX

NOTIFICATION PROCESSED BY IB

01/23/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/05/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/05/2022

NPUB

NOTICE OF PUBLICATION

01/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/16/2021

DOCK

ASSIGNED TO EXAMINER

12/04/2021

MAFR

APPLICATION FILING RECEIPT MAILED

06/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/17/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/14/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/10/2021

Continuous trademark protection

Get notified about every new filing that threatens ACOFIDE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.